Assignee
LUPIN LTD
IN·97 granted patents·90 pending applications·142 citations·filing 1999–2024
Top patents by PatentIndex Score
187 records- 0191US11952380B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2022·Granted Apr 9, 2024·3 cites·20 claims
- 0288US9073943B2Antiviral compounds with a dibenzooxaheterocycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·8 cites·22 claims
- 0385US9399638B2Substituted pyridine compounds as CRAC modulatorsLUPIN LTD·Filed 2013·Granted Jul 26, 2016·11 cites·11 claims
- 0483US11278502B2Modified release formulation of lacosamideLUPIN LTD·Filed 2018·Granted Mar 22, 2022·2 cites·24 claims
- 0583US9073942B2Antiviral compounds with a heterotricycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·9 cites·23 claims
- 0681US9598391B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2015·Granted Mar 21, 2017·4 cites·14 claims
- 0779US11459330B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2018·Granted Oct 4, 2022·3 cites·17 claims
- 0879US10556069B2InhalerLUPIN LTD·Filed 2015·Granted Feb 11, 2020·5 cites·10 claims
- 0978US12391695B2PRMT5 inhibitorsLUPIN LTD·Filed 2020·Granted Aug 19, 2025·1 cites·11 claims
- 1078US9163001B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Oct 20, 2015·4 cites·29 claims
- 1177US9555035B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2016·Granted Jan 31, 2017·2 cites·42 claims
- 1277US9393247B2Heteroaryl derivatives as alpha7 nAChR modulatorsLUPIN LTD·Filed 2015·Granted Jul 19, 2016·3 cites·22 claims
- 1377US8383151B2Pharmaceutical compositions of rifaximinLUPIN LTD·Filed 2008·Granted Feb 26, 2013·4 cites·39 claims
- 1477US7763602B2Pyrrole derivatives as antimycobacterial compoundsLUPIN LTD·Filed 2008·Granted Jul 27, 2010·2 cites·24 claims
- 1576US7470786B2Method for manufacture of ceftriaxone sodiumLUPIN LTD·Filed 2006·Granted Dec 30, 2008·4 cites·21 claims
- 1676US2019192490A1Rifaximin ready-to-use suspensionLUPIN LTD·Filed 2018·Application pending·0 cites
- 1776US2025082615A1Solid dispersion of rifaximinLUPIN LTD·Filed 2024·Application pending·0 cites
- 1874US12435066B2Substituted tricyclic compoundsLUPIN LTD·Filed 2020·Granted Oct 7, 2025·1 cites·27 claims
- 1974US7511135B2Method for manufacture of ceftiofurLUPIN LTD·Filed 2003·Granted Mar 31, 2009·9 cites·19 claims
- 2073US10137114B2Rifaximin ready-to-use suspensionLUPIN LTD·Filed 2015·Granted Nov 27, 2018·1 cites·15 claims
- 2173US9428499B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2013·Granted Aug 30, 2016·2 cites·28 claims
- 2272US9931405B2Pharmaceutical compositions for gastrointestinal drug deliveryLUPIN LTD·Filed 2015·Granted Apr 3, 2018·1 cites·12 claims
- 2372US9227919B2Arylalkylamine compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Jan 5, 2016·2 cites·16 claims
- 2471US9359367B2Tetrahydroquinazolinone derivatives as PARP inhibitorsLUPIN LTD·Filed 2013·Granted Jun 7, 2016·3 cites·19 claims
- 2570US7230097B2Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acidLUPIN LTD·Filed 2004·Granted Jun 12, 2007·7 cites·33 claims
- 2669US9737534B2Oxazoline and isoxazoline derivatives as CRAC modulatorsLUPIN LTD·Filed 2015·Granted Aug 22, 2017·1 cites·8 claims
- 2768US10251850B2Process for preparation of cysteamine bitartrateLUPIN LTD·Filed 2018·Granted Apr 9, 2019·1 cites·4 claims
- 2868US9062067B2Process for preparation of darunavir and darunavir ethanolate of fine particle sizeLUPIN LTD·Filed 2013·Granted Jun 23, 2015·1 cites·27 claims
- 2968US7691889B2Antimycobacterial compoundsLUPIN LTD·Filed 2005·Granted Apr 6, 2010·1 cites·16 claims
- 3067US9969691B2Polymorphic forms of pitavastatin sodiumLUPIN LTD·Filed 2015·Granted May 15, 2018·1 cites·7 claims
- 3166US2025034521A1Mammalian cell culture process for recombinant protein productionLUPIN LTD·Filed 2022·Application pending·0 cites
- 3264US10227317B2Process for the preparation of vortioxetineLUPIN LTD·Filed 2016·Granted Mar 12, 2019·1 cites·7 claims
- 3363US9127029B2Process for preparation of substantially pure fosamprenavir calcium and its intermediatesLUPIN LTD·Filed 2014·Granted Sep 8, 2015·0 cites·4 claims
- 3463US2026035451A1Process for manufacturing antibody fragment proteinLUPIN LTD·Filed 2024·Application pending·0 cites
- 3562US7335767B2Method for preparation of ceftiofur and salts thereofLUPIN LTD·Filed 2003·Granted Feb 26, 2008·3 cites·9 claims
- 3662US2024123169A1Breath actuated inhalerLUPIN LTD·Filed 2023·Application pending·0 cites
- 3761US2024350480A1Stable pharmaceutical composition of methylnaltrexone for an oral administrationLUPIN LTD·Filed 2024·Application pending·0 cites
- 3861US2019076536A1Pharmaceutical compositions for gastrointestinal drug deliveryLUPIN LTD·Filed 2018·Application pending·0 cites
- 3961US2020375959A1Solid dispersion of rifaximinLUPIN LTD·Filed 2020·Application pending·0 cites
- 4060USD948704SInhalerLUPIN LTD·Filed 2019·Granted Apr 12, 2022·7 cites·1 claims
- 4159US2008102134A1Controlled release color stable pharmaceutical dosage form of hmg-coa reductase inhibitors, free of alkalizing or buffering agentsLUPIN LTD·Filed 2007·Application pending·0 cites
- 4258US10259790B2Polymorphic forms of pitavastatin sodiumLUPIN LTD·Filed 2018·Granted Apr 16, 2019·0 cites·6 claims
- 4358US9944639B2Quinolizinone derivatives as PI3K inhibitorsLUPIN LTD·Filed 2015·Granted Apr 17, 2018·1 cites·22 claims
- 4458US2009264341A1Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disordersLUPIN LTD·Filed 2009·Application pending·0 cites
- 4558US2008081069A1Novel controlled release formulations of divalproex sodiumLUPIN LTD·Filed 2007·Application pending·0 cites
- 4658US2009270330A1Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disordersLUPIN LTD·Filed 2009·Application pending·0 cites
- 4757USD948703SInhalerLUPIN LTD·Filed 2019·Granted Apr 12, 2022·6 cites·1 claims
- 4857US9573944B2Heterocyclyl compoundsLUPIN LTD·Filed 2013·Granted Feb 21, 2017·0 cites·25 claims
- 4956US10556942B2Process for the purification of TNFR:Fc fusion proteinLUPIN LTD·Filed 2015·Granted Feb 11, 2020·1 cites·20 claims
- 5056US9969731B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2016·Granted May 15, 2018·0 cites·17 claims
Showing the top 50 of 187 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →